A detailed history of Park Place Capital Corp transactions in Atri Cure, Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 31 shares of ATRC stock, worth $733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31
Previous 116 73.28%
Holding current value
$733
Previous $3,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$19.86 - $29.09 $1,688 - $2,472
-85 Reduced 73.28%
31 $0
Q1 2024

Apr 18, 2024

BUY
$28.21 - $37.78 $874 - $1,171
31 Added 36.47%
116 $3,000
Q4 2023

Jan 24, 2024

SELL
$32.99 - $43.25 $14,680 - $19,246
-445 Reduced 83.96%
85 $3,000
Q1 2023

May 02, 2023

BUY
$35.87 - $47.22 $4,412 - $5,808
123 Added 30.22%
530 $21,000
Q4 2022

Feb 14, 2023

BUY
$33.48 - $47.45 $13,626 - $19,312
407 New
407 $18,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.1B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Park Place Capital Corp Portfolio

Follow Park Place Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Park Place Capital Corp with notifications on news.